Treatment of CYR61- and VEGF-mediated conditions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 4, 2022
Grant Date -
Jul 28, 2016
app pub date -
Sep 4, 2014
filing date -
Sep 6, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates generally to the treatment of CYR61- and VEGF-mediated conditions and, more particularly to the treatment of such conditions by administering to an individual a CYR61 downregulator. In one embodiment, the invention provides a method of treating a CYR61-mediated condition in an individual in need of such treatment, the method comprising: administering to the individual an effective amount of at least one CYR61 downregulator (CYR61DR), wherein the effective amount is an amount sufficient to decrease expression of the CYR61 gene in the individual.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully